Your session is about to expire
← Back to Search
Personalized Invitations for Colorectal Cancer Screening
Phase 3
Waitlist Available
Led By Ronald Myers, PhD
Research Sponsored by Sidney Kimmel Cancer Center at Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Noncompliant with CRC screening in terms of American Cancer Society guidelines
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying whether sending personalized invitations to African Americans for colorectal cancer screening is more effective than standard reminders.
Who is the study for?
This trial is for African American adults who haven't followed the recommended guidelines for colorectal cancer screening, have no family history of this cancer before age 60, haven't been diagnosed with colorectal issues or inflammatory bowel disease, and visited a primary care office in the last two years.Check my eligibility
What is being tested?
The study is testing if personalized invitations to get screened for colorectal cancer are more effective than standard reminders. It's a phase III trial where participants will be randomly assigned to receive either a personalized invitation or a standard reminder.See study design
What are the potential side effects?
Since this trial focuses on increasing screening rather than testing new medications, there aren't direct side effects from interventions. However, typical risks associated with colorectal screenings may include discomfort during procedures and very rare complications like bleeding.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have not followed the recommended guidelines for colorectal cancer screening.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intervention impact on colorectal cancer (CRC) screening utilization over the 6-month observation period
Secondary outcome measures
Intervention impact on CRC screening preference, based on data obtained from both the endpoint chart audit and the endpoint survey
Intervention impact on population health-management representations related to CRC screening, as assessed by perceived salience and coherence and self-efficacy-related CRC screening measured with 6 to 10 Likert-type items on both the baseline and end ...
Find a Location
Who is running the clinical trial?
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityLead Sponsor
162 Previous Clinical Trials
10,015 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,257 Total Patients Enrolled
Ronald Myers, PhDPrincipal InvestigatorJefferson Medical College of Thomas Jefferson University
2 Previous Clinical Trials
3,400 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- No one in my family had colorectal cancer before 60.I have never been diagnosed with colorectal cancer, polyps, or inflammatory bowel disease.I have not followed the recommended guidelines for colorectal cancer screening.I am African-American, see my doctor in a big city, and need a colon cancer screening.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 2 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Would you consider participants who are over the age of 35 for this research?
"This research is for people aged 50-79."
Answered by AI
Has this medication been cleared by the FDA?
"The safety of this medical intervention falls on a 3 due to the fact that it is a Phase 3 trial. In other words, there are multiple rounds of data supporting safety in addition to some evidence for efficacy."
Answered by AI
Are there any current vacancies for participants in this experiment?
"Unfortunately, this particular clinical trial is not presently looking for candidates. Based on the information found on clinicaltrials.gov, which was last edited on December 17th 2013, the study is not recruiting at present. There are 1108 other trials actively recruiting participants though."
Answered by AI
How can I sign up for this opportunity to help contribute to research?
"Eligibility requirements for this trial include being 50 to 79 years old and having a diagnosis of colorectal carcinoma. Out of the 896 total patients needed, how many hopefuls will you be able to screen?"
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger